THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $23,146,000 | +58.2% | 2,196,014 | +7.8% | 0.00% | +33.3% |
| Q3 2015 | $14,628,000 | -60.5% | 2,037,371 | -0.5% | 0.00% | -50.0% |
| Q2 2015 | $37,003,000 | +9.1% | 2,047,753 | -5.1% | 0.01% | +20.0% |
| Q1 2015 | $33,922,000 | +11.2% | 2,157,872 | +0.1% | 0.01% | 0.0% |
| Q4 2014 | $30,505,000 | -16.6% | 2,155,858 | +0.7% | 0.01% | -16.7% |
| Q3 2014 | $36,583,000 | -43.5% | 2,140,603 | -1.5% | 0.01% | -45.5% |
| Q2 2014 | $64,731,000 | +3.6% | 2,173,652 | +7.7% | 0.01% | 0.0% |
| Q1 2014 | $62,470,000 | -13.7% | 2,019,066 | -0.6% | 0.01% | -15.4% |
| Q4 2013 | $72,419,000 | +2.4% | 2,031,401 | +17.4% | 0.01% | -7.1% |
| Q3 2013 | $70,737,000 | +4.9% | 1,730,784 | -1.1% | 0.01% | 0.0% |
| Q2 2013 | $67,452,000 | – | 1,750,640 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |